(NASDAQ:ETNB – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Cantor ...

WASHINGTON (Reuters) - Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75-million penalty to settle Securities ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Cantor Fitzgerald CEO Howard Lutnick is co-chair of the transition team for Donald Trump. The SEC says his firm caused two ...

Cantor Fitzgerald has recently initiated ARS Pharmaceuticals Inc (SPRY) stock to Overweight rating, as announced on August 20, 2024, according to Finviz. Earlier, on August 13, 2024, Raymond James had ...

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

As we enter the new year, cryptocurrency has been enjoying a thriving environment, with every angle turning out in its favor.

Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of CVS Health in a report issued on Tuesday, December 31st.

Trump and his associates have embraced crypto enthusiastically. His nominee for commerce secretary, Howard Lutnick, controls ...

Cantor Fitzgerald raised the firm’s price target on Axsome Therapeutics (AXSM) to $124 from $121 and keeps an Overweight rating on the shares ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...